I oligonucleotidi antisenso sono la prima terapia genica (in realtà terapia con RNA antisenso, poiché non modificano il codice genetico) disponibile sul mercato per il trattamento di malattie neurogenetiche. Si basano sulla tecnica del salto dell'esone (Duchenne) o della inclusione dell'esone (AME). Presto sarà disponibile anche il trattamento per la distrofia miotonica di Steinert.

Esquema de los mecanismos de acción de los oligonucleótidos antisentido mediante el cambio de empalme. Se ilustra la inclusión del exón 7 en la atrofia muscular espinal y el salto del exón 51 en la distrofia muscular de Duchenne.
Figura 1. Esquema de los mecanismos de acción de los oligonucleótidos antisentido mediante el cambio de empalme. Se ilustra la inclusión del exón 7 en la atrofia muscular espinal y el salto del exón 51 en la distrofia muscular de Duchenne.
19955111 {19955111:JMSPQW4N} 1 vancouver 50 default 3561 https://neuropediatoolkit.org/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3Afalse%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22JMSPQW4N%22%2C%22library%22%3A%7B%22id%22%3A19955111%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Daguenet%20et%20al.%22%2C%22parsedDate%22%3A%222015-12%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%20style%3D%26quot%3Bclear%3A%20left%3B%20%26quot%3B%26gt%3B%5Cn%20%20%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-left-margin%26quot%3B%20style%3D%26quot%3Bfloat%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%26quot%3B%26gt%3B1.%26lt%3B%5C%2Fdiv%26gt%3B%26lt%3Bdiv%20class%3D%26quot%3Bcsl-right-inline%26quot%3B%20style%3D%26quot%3Bmargin%3A%200%20.4em%200%201.5em%3B%26quot%3B%26gt%3BDaguenet%20E%2C%20Dujardin%20G%2C%20Valc%26%23xE1%3Brcel%20J.%20The%20pathogenicity%20of%20splicing%20defects%3A%20mechanistic%20insights%20into%20pre-mRNA%20processing%20inform%20novel%20therapeutic%20approaches.%20EMBO%20reports%20%5BInternet%5D.%202015%20Dec%20%5Bcited%202022%20Nov%203%5D%3B16%2812%29%3A1640%26%23x2013%3B55.%20Available%20from%3A%20%26lt%3Ba%20class%3D%26%23039%3Bzp-ItemURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fwww.embopress.org%5C%2Fdoi%5C%2Ffull%5C%2F10.15252%5C%2Fembr.201541116%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fwww.embopress.org%5C%2Fdoi%5C%2Ffull%5C%2F10.15252%5C%2Fembr.201541116%26lt%3B%5C%2Fa%26gt%3B%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%20%20%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22The%20pathogenicity%20of%20splicing%20defects%3A%20mechanistic%20insights%20into%20pre-mRNA%20processing%20inform%20novel%20therapeutic%20approaches%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elisabeth%22%2C%22lastName%22%3A%22Daguenet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gwendal%22%2C%22lastName%22%3A%22Dujardin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Juan%22%2C%22lastName%22%3A%22Valc%5Cu00e1rcel%22%7D%5D%2C%22abstractNote%22%3A%22Abstract%20Removal%20of%20introns%20from%20pre-mRNA%20precursors%20%28pre-mRNA%20splicing%29%20is%20a%20necessary%20step%20for%20the%20expression%20of%20most%20genes%20in%20multicellular%20organisms%2C%20and%20alternative%20patterns%20of%20intron%20removal%20diversify%20and%20regulate%20the%20output%20of%20genomic%20information.%20Mutation%20or%20natural%20variation%20in%20pre-mRNA%20sequences%2C%20as%20well%20as%20in%20spliceosomal%20components%20and%20regulatory%20factors%2C%20has%20been%20implicated%20in%20the%20etiology%20and%20progression%20of%20numerous%20pathologies.%20These%20range%20from%20monogenic%20to%20multifactorial%20genetic%20diseases%2C%20including%20metabolic%20syndromes%2C%20muscular%20dystrophies%2C%20neurodegenerative%20and%20cardiovascular%20diseases%2C%20and%20cancer.%20Understanding%20the%20molecular%20mechanisms%20associated%20with%20splicing-related%20pathologies%20can%20provide%20key%20insights%20into%20the%20normal%20function%20and%20physiological%20context%20of%20the%20complex%20splicing%20machinery%20and%20establish%20sound%20basis%20for%20novel%20therapeutic%20approaches.%22%2C%22date%22%3A%222015-12%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.15252%5C%2Fembr.201541116%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.embopress.org%5C%2Fdoi%5C%2Ffull%5C%2F10.15252%5C%2Fembr.201541116%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%221469-221X%22%2C%22language%22%3A%22%22%2C%22collections%22%3A%5B%228PUZ7DEQ%22%2C%22RUSQH6B4%22%5D%2C%22dateModified%22%3A%222026-10-27T22%3A56%3A49Z%22%7D%7D%5D%7D
1.
Daguenet E, Dujardin G, Valcárcel J. The pathogenicity of splicing defects: mechanistic insights into pre-mRNA processing inform novel therapeutic approaches. EMBO reports [Internet]. 2015 Dec [cited 2022 Nov 3];16(12):1640–55. Available from: https://www.embopress.org/doi/full/10.15252/embr.201541116